Somnapure
NDC 69721-003
Product Information
Somnapure is a OTC MONOGRAPH FINAL-approved product labeled by Nutraclick, Llc. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a blue product. This product entry covers the primary NDC 69721-003 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
44687
Code Structure Chart
Product Details
What is NDC 69721-003?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- DIPHENHYDRAMINE HYDROCHLORIDE (UNII: TC2D6JAD40)
- DIPHENHYDRAMINE (UNII: 8GTS82S83M) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)
- FD&C BLUE NO. 1 (UNII: H3R47K3TBD)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- POLYETHYLENE GLYCOLS (UNII: 3WJQ0SDW1A)
- POLYVINYL ALCOHOL, UNSPECIFIED (UNII: 532B59J990)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- STEARIC ACID (UNII: 4ELV7Z65AP)
- TALC (UNII: 7SEV7J4R1U)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1085945 - diphenhydrAMINE HCl 50 MG Oral Tablet
- RxCUI: 1085945 - diphenhydramine hydrochloride 50 MG Oral Tablet
- RxCUI: 1609070 - Somnapure Clinical Strength 50 MG Oral Tablet
- RxCUI: 1609070 - diphenhydramine hydrochloride 50 MG Oral Tablet [Somnapure]
- RxCUI: 1609070 - Somnapure 50 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.